BackBelite Bio Overview

Belite Bio Other Current Assets

Latest other current assets for BLTE: $520M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$521.86M
↑ 227.62% YoYΔ $362.58M vs prior year quarter

Peer average

Loading

Belite Bio Other Current Assets History

Loading

Belite Bio vs. peers: Other Current Assets Comparison

Loading

Belite Bio Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Belite Bio (BLTE) FAQ

As of the most recent data (March 2026), BLTE shows a other current assets of $520M. That compares with $160M in the prior-year period — up 227.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLTE's other current assets is now $520M (was $160M) — a 227.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Belite Bio is outperforming or lagging.

Tracking BLTE's other current assets over time shows whether Belite Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $520M That compares with $160M in the prior-year period — up 227.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Belite Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $520M) with ownership activity and broader fundamentals.